OptimizeRx Launches ‘Digital Healthcare’ Webinar Series
Session 1: “
This session will focus on OptimizeRx’s latest integration of
Date:
Time:
Session 2: “Improving Adherence Via Interactive Messaging”
This session will focus on the barriers to successful therapy adherence, including treatment affordability, confusing therapy regimens, unexpected side effects, and more. It will address how to overcome the barriers to successful therapy adherence and engage patients throughout their healthcare journey.
Date:
Time:
Session 3: “Technology Interoperability Throughout the Care Journey”
This session will provide a behind-the-scenes view into how six independent and dynamic health technologies help support a 40-year-old patient who has been diagnosed with colon cancer. It will demonstrate how the patient’s medical team is able to seamlessly exchange valuable clinical data and create a comprehensive care plan for the best overall outcome.
Date:
Time:
The webinar sessions are free and open to anyone in the industry, and will provide an opportunity to engage directly with
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions, contact media relations at (754) 245-7070 or malejandra@optimizerx.com.
About
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information.
For more information, follow the company on Twitter, LinkedIn or visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
OptimizeRx Contact
Tel (248) 651-6568 x807
dbaker@optimizerx.com
Media Relations Contact
Tel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact
Tel (949) 432-7557
oprx@cma.team
Source: OptimizeRx Corporation